ReShape LifesciencesRSLS
Market Cap: $3.76M
About: Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
Employees: 31
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
49% more capital invested
Capital invested by funds: $49.1K [Q1] → $73.3K (+$24.2K) [Q2]
0.52% more ownership
Funds ownership: 1.14% [Q1] → 1.65% (+0.52%) [Q2]
11% less funds holding
Funds holding: 18 [Q1] → 16 (-2) [Q2]
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Research analyst outlook
We haven’t received any recent analyst ratings for RSLS.